The HIV-1 REV Trans-Activator is a Sequence Specific RNA Binding Protein

  • Michael H. Malim
  • David F. McCarn
  • Laurence S. Tiley
  • Bryan R. Cullen
Part of the NATO ASI Series book series (volume 49)

Abstract

The pathogenic human retrovirus, human immunodeficiency virus type 1 (HIV-1), is the major etiologic agent of the acquired immunodeficiency syndrome (AIDS) (Fauci, 1988). HIV-1, along with the related primate immunodeficiency viruses, HIV-2 and simian immunodeficiency virus (SIV), is a member of a subfamily of retroviruses known as lentiviruses. Other members of this subfamily include visna virus, caprine arthritis encephalitis virus (CAEV), equine infectious anemia virus (EIAV) and feline immunodeficiency virus (FIV). Lentivirus infection of the susceptible host typically results in a prolonged and chronic disease state affecting the immune and nervous systems as well as cells in a variety of other tissues (reviewed by Haase, 1986). Interestingly, these viruses display complex patterns of gene expression that are very different from those of the extensively studied Type C family of retroviruses. Specifically, proviral activation from a frequently extended period of latency is followed by a pattern of viral gene expression that is markedly temporal. During this time a number of differentially spliced viral transcripts may be observed.

Keywords

Arthritis Leukemia Electrophoresis Anemia Polyacrylamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arya SK, Guo C, Josephs SF, Wong-Staal F (1985) Trans- activator gene of human T-lymphotropic virus type III ( HTLV-III ). Science 229: 69–73.Google Scholar
  2. Berkhout B, Silverman RH, Jeang K-T (1989) Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59: 273–282.PubMedCrossRefGoogle Scholar
  3. Chang DD, Sharp PA (1989) Regulation by HIV Rev depends upon recognition of splice sites. Cell 59: 789–795.Google Scholar
  4. Cullen BR, Greene WC (1989) Regulatory pathways governing HIV-1 replication. Cell 58: 423–426.PubMedCrossRefGoogle Scholar
  5. Daly TJ, Cook KS, Gray GS, Maione TE, Rusche JR (1989) Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342: 816–819.Google Scholar
  6. Dayton ET, Powell DM, Dayton AI (1989) Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. Science 246: 1625–1629.Google Scholar
  7. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, Valerio R (1989) Human immunodeficiency virus 1 Tat protein binds trans-activation-responsive region ( TAR) RNA in vitro. Proc Natl Acad Sci USA 86: 6925–6929.Google Scholar
  8. Emerman M, Vazeux R, Peden K (1989) The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57: 1155–1165.PubMedCrossRefGoogle Scholar
  9. Fauci AS (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617–622.PubMedCrossRefGoogle Scholar
  10. Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wong-Staal F (1986) HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46: 807–817.PubMedCrossRefGoogle Scholar
  11. Felber BK, Hadzopoulou-Cladaras M, Cladaras C, Copeland T, Pavlakis GN (1989) Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sei USA 86: 1495–1499.Google Scholar
  12. Haase AT (1986) Pathogenesis of lentivirus infections. Nature 322: 130 - 136.PubMedCrossRefGoogle Scholar
  13. Hammarskjold M-L, Heimer J, Hammarskjold B, Sangwan I, Albert L, Rekosh D (1989) Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol 63: 1959–1966.PubMedGoogle Scholar
  14. Heaphy S, Dingwall C, Ernberg I, Gait MJ, Green SM, Karn J, Lowe AD, Singh M, Skinner MA (1990) HIV-1 regulator of virion expression ( Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60: 685–693.Google Scholar
  15. Lazinski D, Grzadzielska E, Das A (1989) Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell 59: 207–218.PubMedCrossRefGoogle Scholar
  16. Malim MH, Böhnlein S, Hauber J, Cullen BR (1989a) Functional dissection of the HIV-1 Rev trans-activator—derivation of a trans-dominant repressor of Rev function. Cell 58: 205–214.Google Scholar
  17. Malim MH, Hauber J, Le S-Y, Maizel JV, Cullen BR (1989b) The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254–257.PubMedCrossRefGoogle Scholar
  18. Malim MH, Tiley LS, McCarn DF, Rusche JR, Hauber J, Cullen BR (1990) HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60: 675–683.Google Scholar
  19. Olsen HS, Nelbock P, Cochrane AW, Rosen CA (1990) Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247:845–848Google Scholar
  20. Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335: 683–689.PubMedCrossRefGoogle Scholar
  21. Rosen CA, Terwilliger E, Dayton A, Sodroski JG, Haseltine WA (1988) Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci USA 85: 2071–2075.PubMedCrossRefGoogle Scholar
  22. Sharp PA, Marciniak RA (1989) HIV TAR: an RNA enhancer? Cell 59: 229–230.PubMedCrossRefGoogle Scholar
  23. Sodroski J, Rosen C, Wong-Staal F, Salahuddin SZ, Popovic M, Arya S, Gallo RC, Haseltine WA (1985) Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 227: 171–173.PubMedCrossRefGoogle Scholar
  24. Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W (1986) A second post-transcriptional trans- activator gene required for HTLV-III replication. Nature 321: 412–417.PubMedCrossRefGoogle Scholar
  25. Zapp ML, Green MR (1989) Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342: 714–716.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Michael H. Malim
    • 1
    • 2
    • 3
    • 4
  • David F. McCarn
    • 1
    • 2
    • 3
    • 4
  • Laurence S. Tiley
    • 1
    • 2
    • 3
    • 4
  • Bryan R. Cullen
    • 1
    • 2
    • 3
    • 4
  1. 1.Howard Hughes Medical InstituteDuke University Medical CenterDurhamUSA
  2. 2.Department of MedicineDuke University Medical CenterDurhamUSA
  3. 3.Department of MicrobiologyDuke University Medical CenterDurhamUSA
  4. 4.Department of ImmunologyDuke University Medical CenterDurhamUSA

Personalised recommendations